-
Policy Matters
Toward Improved Dosing in the Precision Oncology EraA forthcoming article series outlines considerations for the dose optimization of modern oncology drugs.
by Brad Davidson, PhD
-
Get Involved
Stitching SupportFourteen-year-old Giuliana Demma sews colorful hospital gowns for children receiving cancer treatment.
by Thomas Celona
-
Facts and Stats
A Broader View of ResearchPeople diagnosed with cancer can participate in various kinds of studies.
by Thomas Celona
-
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
Policy Matters
Progress in the Youth E-cigarette EpidemicNew data reveal a decrease in youth e-cigarette use but underscore the need for continued policy and advocacy efforts.
by Brad Davidson, PhD
-
Get Involved
Treasure TroveThe Pediatric Oncology Treasure Chest Foundation provides toys and gifts to young cancer patients.
by Thomas Celona
-
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
-
Forward Look
Medicare Rule Expands Access to Navigation ServicesExperts hope Medicare reimbursement for patient navigation will allow more treatment sites to offer this assistance.
by Carolyn Bernhardt
-
Forward Look
The Cost of Dental Side EffectsHead and neck cancer survivors often face significant costs for treatments not covered by health insurance.
by Kris Conner
-
Policy Matters
The Future of Perioperative Clinical Trial DesignsA recent FDA-AACR workshop explored best practices for trial design, analysis and interpretation of clinical studies with multiple phases of treatment.
by Elizabeth M. Jaffee, MD
Study finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
